NM_000288.4:c.653C>T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000288.4(PEX7):c.653C>T(p.Ala218Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000452 in 1,613,612 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000288.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEX7 | NM_000288.4 | c.653C>T | p.Ala218Val | missense_variant | Exon 7 of 10 | ENST00000318471.5 | NP_000279.1 | |
PEX7 | NM_001410945.1 | c.539C>T | p.Ala180Val | missense_variant | Exon 7 of 10 | NP_001397874.1 | ||
PEX7 | XM_006715502.3 | c.359C>T | p.Ala120Val | missense_variant | Exon 4 of 7 | XP_006715565.1 | ||
PEX7 | XM_047418874.1 | c.526+23728C>T | intron_variant | Intron 5 of 5 | XP_047274830.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251372Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135852
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1461488Hom.: 0 Cov.: 30 AF XY: 0.0000536 AC XY: 39AN XY: 727066
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74322
ClinVar
Submissions by phenotype
Rhizomelic chondrodysplasia punctata type 1 Pathogenic:4Other:1
Variant summary: PEX7 c.653C>T (p.Ala218Val) results in a non-conservative amino acid change located in the WD40-repeat-containing domain (IPR017986) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 3.2e-05 in 251372 control chromosomes. c.653C>T has been reported in the literature in multiple individuals affected with Rhizomelic Chondrodysplasia Punctata Type (example, Braverman_1997, Shimozawa_1999, Braverman_2002, Motley_2002). These data indicate that the variant is very likely to be associated with disease. At least two publications report experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in impaired transport of PTS2 (peroxisome-targeting signal type 2 (PTS2) nonapeptide sequence) signal containing proteins into the peroxisomes (Braverman_1997, Mukai_2002). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
NM_000288.3(PEX7):c.653C>T(A218V) is classified as likely pathogenic in the context of rhizomelic chondrodysplasia punctata type 1. Sources cited for classification include the following: PMID 12325024, 9090382, 9090381 and 11756410. Classification of NM_000288.3(PEX7):c.653C>T(A218V) is based on the following criteria: This variant has been observed more frequently in patients with clinical diagnoses than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. -
- -
not provided Pathogenic:3
Published functional studies demonstrate that the variant severely impairs protein function (PMID: 9090381); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 9090381, 11756410, 10083738, 12325024, 31589614, 33337545, 11781871) -
- -
- -
Peroxisome biogenesis disorder 9B Pathogenic:3
- -
- -
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 218 of the PEX7 protein (p.Ala218Val). This variant is present in population databases (rs121909151, gnomAD 0.006%). This missense change has been observed in individuals with rhizomelic chondrodysplasia punctata (PMID: 9090381, 10083738, 11781871, 12325024). ClinVar contains an entry for this variant (Variation ID: 7781). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change affects PEX7 function (PMID: 11756410, 11781871). For these reasons, this variant has been classified as Pathogenic. -
PEX7-related disorder Pathogenic:1
The PEX7 c.653C>T variant is predicted to result in the amino acid substitution p.Ala218Val. This variant has been reported to be the second most common pathogenic PEX7 variant and accounts for ~6-12% of the RCDP cases (Braverman et al. 1997. PubMed ID: 9090381; Motley et al. 2002. PubMed ID: 11781871).This variant is reported in 0.0062% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -
Phytanic acid storage disease;C1859133:Rhizomelic chondrodysplasia punctata type 1;C2749346:Peroxisome biogenesis disorder 9B Pathogenic:1
- -
Rhizomelic chondrodysplasia punctata Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at